Det verkar som ett fel inträffade när du försökte ladda denna sida.
Vårt team har meddelats men vänligen kontakta oss via widget för e-postsupport om problemet kvarstår.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 4,9x - 5,4x | 5,1x |
| Selected Fwd Revenue Multiple | 4,1x - 4,6x | 4,3x |
| Fair Value | ₺14,44 - ₺16,58 | ₺15,51 |
| Upside | -11,8% - 1,3% | -5,3% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Aksa Enerji Üretim A.S. | AKSEN | IBSE:AKSEN |
| Consus Enerji Isletmeciligi ve Hizmetleri A.S. | CONSE | IBSE:CONSE |
| Mogan Enerji Yatirim Holding Anonim Sirketi | MOGAN | IBSE:MOGAN |
| Biotrend Cevre ve Enerji Yatirimlari A.S. | BIOEN | IBSE:BIOEN |
| Galata Wind Enerji A.S. | GWIND | IBSE:GWIND |
| Akfen Yenilenebilir Enerji | AKFYE | IBSE:AKFYE |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| AKSEN | CONSE | MOGAN | BIOEN | GWIND | AKFYE | |||
| IBSE:AKSEN | IBSE:CONSE | IBSE:MOGAN | IBSE:BIOEN | IBSE:GWIND | IBSE:AKFYE | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | 41.5% | NM- | NM- | 96.4% | 56.9% | 59.0% | ||
| 3Y CAGR | 31.6% | 54.4% | 57.7% | 84.5% | 63.6% | 58.1% | ||
| Latest Twelve Months | -37.7% | -19.7% | -29.8% | -16.6% | -11.9% | -19.1% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | 15.2% | -3.3% | 12.5% | 10.7% | 61.9% | 28.2% | ||
| Prior Fiscal Year | 18.5% | -20.0% | 14.7% | 1.9% | 55.0% | 47.0% | ||
| Latest Fiscal Year | 16.9% | 4.2% | -2.6% | -13.7% | 42.2% | 34.1% | ||
| Latest Twelve Months | 16.9% | 4.2% | -2.6% | -13.7% | 42.2% | 34.1% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 2.28x | 2.88x | 4.60x | 4.59x | 6.04x | 5.15x | ||
| EV / LTM EBIT | 13.5x | 69.0x | -175.4x | -33.6x | 14.3x | 15.1x | ||
| Price / LTM Sales | 1.30x | 1.46x | 1.62x | 3.27x | 5.63x | 3.77x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 2.28x | 4.59x | 6.04x | |||||
| Historical EV / LTM Revenue | 3.06x | 4.10x | 5.15x | |||||
| Selected EV / LTM Revenue | 4.87x | 5.12x | 5.38x | |||||
| (x) LTM Revenue | 5,097 | 5,097 | 5,097 | |||||
| (=) Implied Enterprise Value | 24,817 | 26,123 | 27,429 | |||||
| (-) Non-shareholder Claims * | (7,024) | (7,024) | (7,024) | |||||
| (=) Equity Value | 17,793 | 19,099 | 20,405 | |||||
| (/) Shares Outstanding | 1,197.0 | 1,197.0 | 1,197.0 | |||||
| Implied Value Range | 14.86 | 15.96 | 17.05 | |||||
| FX Rate: TRY/TRY | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 14.86 | 15.96 | 17.05 | 16.37 | ||||
| Upside / (Downside) | -9.2% | -2.5% | 4.1% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | AKSEN | CONSE | MOGAN | BIOEN | GWIND | AKFYE | |
| Enterprise Value | 74,108 | 3,965 | 59,652 | 12,670 | 14,617 | 26,618 | |
| (+) Cash & Short Term Investments | 1,057 | 27 | 3,009 | 99 | 1,318 | 1,159 | |
| (+) Investments & Other | 6 | 0 | 0 | 319 | 94 | 1 | |
| (-) Debt | (28,167) | (1,979) | (32,143) | (3,953) | (2,292) | (8,085) | |
| (-) Other Liabilities | (3,886) | 0 | (9,240) | (10) | 0 | (99) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 43,118 | 2,012 | 21,278 | 9,125 | 13,738 | 19,594 | |
| (/) Shares Outstanding | 1,226.3 | 771.0 | 2,440.1 | 500.0 | 540.0 | 1,197.0 | |
| Implied Stock Price | 35.16 | 2.61 | 8.72 | 18.25 | 25.44 | 16.37 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 35.16 | 2.61 | 8.72 | 18.25 | 25.44 | 16.37 | |
| Trading Currency | TRY | TRY | TRY | TRY | TRY | TRY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |